CYP 10.2% 27.0¢ cynata therapeutics limited

The Phase I/IIb Nereid Study Is Now Registered, page-3

  1. 1,888 Posts.
    lightbulb Created with Sketch. 1131
    MCA -maybe mesenchymal cells from autologous sources - so specifically ipscs where the four factors involved in doing the induction of pluripotency are applied to an autologous source and what is then done is that the ipscs are directed towards a mesenchymal fate --- is that what is going on there ?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
0.025(10.2%)
Mkt cap ! $48.50M
Open High Low Value Volume
26.0¢ 28.5¢ 26.0¢ $59.33K 217.6K

Buyers (Bids)

No. Vol. Price($)
1 8000 25.5¢
 

Sellers (Offers)

Price($) Vol. No.
26.0¢ 30000 1
View Market Depth
Last trade - 15.35pm 15/05/2024 (20 minute delay) ?
Last
25.5¢
  Change
0.025 ( 4.08 %)
Open High Low Volume
26.5¢ 29.0¢ 25.5¢ 27094
Last updated 15.35pm 15/05/2024 ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.